
MASSDEVICE ON CALL — Following the U.S. House of Representatives’ sweeping repeal of the impending 2.3% medical device tax, lobbying efforts have turned to urging the Dem-led Senate to follow suit.
As a Senate bill repealing the medical device tax languishes without Democratic support, some have speculated that repeal efforts are dead in the water, but AdvaMed president & CEO Stephen Ubl took to the opinion pages to urge the nation’s upper house to spike the levy.